Literature DB >> 1325734

The genetics of Wilms' tumor.

D A Haber1, D E Housman.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1325734     DOI: 10.1016/s0065-230x(08)60302-4

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  12 in total

1.  Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer.

Authors:  G B Silberstein; K Van Horn; P Strickland; C T Roberts; C W Daniel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells.

Authors:  D A Haber; H T Timmers; J Pelletier; P A Sharp; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.

Authors:  S Maheswaran; C Englert; G Zheng; S B Lee; J Wong; D P Harkin; J Bean; R Ezzell; A J Garvin; R T McCluskey; J A DeCaprio; D A Haber
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

4.  A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.

Authors:  R W Johnstone; R H See; S F Sells; J Wang; S Muthukkumar; C Englert; D A Haber; J D Licht; S P Sugrue; T Roberts; V M Rangnekar; Y Shi
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

5.  Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.

Authors:  C Englert; M Vidal; S Maheswaran; Y Ge; R M Ezzell; K J Isselbacher; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

6.  Physical and functional interaction between WT1 and p53 proteins.

Authors:  S Maheswaran; S Park; A Bernard; J F Morris; F J Rauscher; D E Hill; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 7.  Tumor suppressor genes in molecular medicine.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Clin Investig       Date:  1994-08

8.  Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development.

Authors:  Shengli Cai; Jeffrey I Everitt; Hiroyuki Kugo; Jennifer Cook; Elena Kleymenova; Cheryl Lyn Walker
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 9.  Regulation of gene expression by WT1 in development and tumorigenesis.

Authors:  Leif W Ellisen
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

10.  Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.

Authors:  H Nakagama; G Heinrich; J Pelletier; D E Housman
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.